⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL211089 | 0.71 | — | — | |
| SCHEMBL18328150 | 0.69 | — | — | |
| SCHEMBL15996557 | 0.69 | — | — | |
| SCHEMBL15492711 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL7809058 | 0.67 | CA1 (0.31) | — | |
| SCHEMBL17993982 | 0.65 | — | — | |
| SCHEMBL13910092 | 0.65 | — | — | |
| SCHEMBL21163167 | 0.65 | — | — | |
| SCHEMBL22700351 | 0.65 | — | — | |
| SCHEMBL15506179 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12038650-B2 | Multilayer phase difference plate, polarizing plate, and image display device | ZEON CORPORATION (JP) | 2024-07-16 | — | — | US | disclosed |
| WO-2024015478-A2 | COMBINATION THERAPIES OF WDR5 INHIBITORS AND PD-1 INHIBITORS | HUYABIO INTERNATIONAL, LLC (US) | 2024-01-18 | — | — | WO | disclosed |
| US-11829036-B2 | Optically anisotropic multilayer product and method for producing same | ZEON CORPORATION (JP) | 2023-11-28 | — | — | US | disclosed |
| WO-2017205684-A1 | COMBINATION THERAPIES WITH FARNESOID X RECEPTOR (FXR) MODULATORS | AKARNA THERAPEUTICS, LTD. (GB) | 2017-11-30 | — | — | WO | disclosed |
| WO-2017205633-A1 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | AKARNA THERAPEUTICS, LTD. (GB) | 2017-11-30 | — | — | WO | disclosed |
| EP-3081213-A1 | TRICYCLIC COMPOUND | Kyowa Hakko Kirin Co., Ltd. (JP) | 2016-10-19 | — | — | EP | disclosed |
| WO-2016103037-A1 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | AKARNA THERAPEUTICS, LTD. (GB) | 2016-06-30 | — | — | WO | disclosed |
| WO-2016081918-A1 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE | AKARNA THERAPEUTICS, LTD. (GB) | 2016-05-26 | — | — | WO | disclosed |
| WO-2015153959-A2 | SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-10-08 | — | — | WO | disclosed |
| WO-2015014261-A1 | MACROLIDE COMPOUND OR SALT THEREOF, SYNTHESIS METHOD, PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF | 上海医药工业研究院 (CN) | 2015-02-05 | — | — | WO | disclosed |
| EP-2089453-B1 | FLUORINATED LUBRICANTS | SOLVAY SPECIALTY POLYMERS IT (IT) | 2014-03-05 | — | — | EP | disclosed |
| EP-1661892-B1 | CONDENSED RING COMPOUND AND USE THEREOF | ONO PHARMACEUTICAL CO (JP) | 2013-07-24 | — | — | EP | disclosed |
| WO-2013078123-A1 | HETEROCYCLIC INHIBITORS OF GLUTAMINASE | CALITHERA BIOSCIENCES INC. (US) | 2013-05-30 | — | — | WO | disclosed |
| US-20120322807-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-12-20 | — | — | US | disclosed |
| US-20120238750-A1 | AROMATIC COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-09-20 | — | — | US | disclosed |
| WO-2012083165-A1 | NOVEL SUBSTITUTED BICYCLIC AROMATIC COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 PHARMACEUTICALS, LLC (US) | 2012-06-21 | — | — | WO | disclosed |